MedTrace Logo

Screening for Masked Hypertension With Smart Wearable Devices (SMART)

NCT05409898 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2022-06-08

No results posted yet for this study

Summary

In recent years, a large number of consumer-grade and Smart Wearable Devices (SWD) such as smart watches, with BP measurement property, have entered the market and have a high configuration and utilization among young and middle-aged populations, but most of them are uncalibrated and have poor accuracy. Recently, several medical-grade smart BP watches have passed the national medical device registration test, which will provide an important tool for accurate screening of hypertension, especially masked hypertension, in young and middle-aged people.

"Screening for masked hypertension in young and middle-aged adults with smart wearable devices" （SMART）aims to screen for masked hypertension using smart BP watches that have been tested for national medical device registration. It is planned to include 200 young and middle-aged subjects with normal blood pressure (BP) in the clinic, who will wear the smart BP watch for 7 consecutive days (BP will be measured at least once in the morning and once in the evening, 2-3 times each time), and if the mean BP is \>= 135/85 mmHg, it will be determined to be MK and recommended for further consultation and treatment.

Conditions

  • Masked Hypertension

Interventions

DEVICE

smart wearable device

screening masked hypertension with smart wearable devices

Sponsors & Collaborators

  • HUAWEI

    collaborator UNKNOWN

  • Jing Liu

    lead OTHER

Principal Investigators

  • Jing Liu, MD · Peking University People's Hospital

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-07-31
Primary Completion
2024-06-30
Completion
2024-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05409898 on ClinicalTrials.gov